Table 1. Epidemio-clinical, histological and immunopathological characteristics of the 31 patients with LAD
Case |
Age (y) |
Sex |
Age at onset (y) |
Pruritus |
Mucous membrane involvement |
Localization |
Aspects of lesions |
Histology |
DIF |
IIF |
1 |
6 |
M |
5.5 |
- |
conjonctiva genitalia |
Face, forearms, knee |
Bullae and crusted erosions |
Subepidermal bullae (SEB), dermal inflammation with eosinophils |
Predominant linear IgA deposits with IgG on DEJ |
- |
2 |
4 |
F |
NP |
+ |
- |
Trunk, limbs |
Bullea , infected erosions |
SEB, eosinophils |
Predominant linear IgA deposits with C3 on DEJ |
NPF |
3 |
11 |
F |
11 |
+ |
- |
Face, limbs |
Vesiculo-bullaes, erosions, erythema |
SEB, eosinophils |
Linear IgA deposits on DEJ |
NPF |
4 |
3 |
F |
3 |
+ |
- |
Trunk, limbs |
Infected bullea, erythema |
SEB, eosinophils |
Predominant linear IgA deposits with C3 on DEJ |
NPF |
5 |
11 |
F |
NP |
NP |
NP |
NP |
NP |
SEB, eosinophils in the papilla |
Predominant linear IgA deposits with IgG on DEJ |
NP |
6 |
1.8 |
F |
NP |
+ |
- |
Scalp, face, buttocks, limbs |
Pseudo-urticarial erythema, bullea, erosions |
SEB, eosinophils, neutrophils , dermal inflammation |
Linear IgA deposits on DEJ |
NPF |
7 |
6 |
M |
6 |
+ |
- |
Face, neck |
Bullea, erosions, erythema |
SEB, eosinophils, dermal inflammation |
Predominant linear IgA deposits with IgG, C3 |
Circulating IgG |
8 |
1.5 |
M |
1 |
+ |
- |
Face, trunk, limbs |
Erythema, Bullae, erosions |
SEB, eosinophils, dermal inflammation |
Predominant linear IgA deposits with IgM |
NPF |
9 |
2 |
M |
2 |
+ |
- |
Leg, arms, forearms |
Vesiculo-bullae, crusted erosions, |
SEB, eosinophils, dermal inflammation |
Linear IgA deposits |
NPF |
10 |
0.6 |
M |
0.8 |
+ |
- |
Face, neck, hands, thighs |
Bullae |
SEB, eosinophils in pthe papilla, dermal inflammation |
Linear IgA deposits |
NPF |
11 |
4.5 |
M |
4.5 |
+ |
Cheilitis, conjunctivitis |
Scalp, neck, back, limbs |
Infected bullae |
SEB, eosinophils and neutrophils in inflammatory dermis |
Predominant linear IgA deposits with C3
|
NPF |
12 |
3 |
M |
3 |
+ |
- |
Genitalia, lower limbs |
Infected bullae |
SEB, eosinophils, dermal inflammation |
Linear IgA deposits |
NPF |
13 |
4 |
M |
3 |
+ |
- |
Face, trunk, hands, lower legs |
Veciculo-bullae, erosions |
NP |
Predominant linear IgA deposits with IgM |
NPF |
14 |
15 |
M |
14 |
+ |
- |
Scalp, face, trunk, limbs |
Erythema, vesiculo-bullae |
SEB, eosinophils, dermal inflammation |
Linear IgA deposit |
- |
15 |
5 |
M |
5 |
- |
Genitalia |
Face, buttocks, limbs |
Erythema, vesiculo-bullae, erosions |
SEB, eosinophils, dermal inflammation |
Predominant linear IgA deposits with C1q |
NPF |
16 |
8 |
M |
8 |
+ |
- |
Limbs |
Erythema, vesiculo-bullae, pustules, impetigo like lesions |
SEB, eosinophils and neutrophils in the dermis |
Predominant linear IgA deposits with IgM and C1q on DEJ |
NPF |
17 |
3 |
M |
2.5 |
+ |
- |
Chest, perineum, lower legs |
Annular bullae with impetigo like lesions |
NP |
Predominant linear IgA deposits on DEJ |
NPF |
18 |
2.5 |
M |
1.5 |
+ |
- |
Face, trunk, genitalia, limbs |
Erythema, vesiculo-bullae |
SEB, eosinophils and neutrophils in the dermis |
Predominant linear IgA deposits with C3 on DEJ |
Circulating IgG anti BMZ |
19 |
1 |
M |
1 |
+ |
- |
Scalp, face, genitalia, limbs |
Erythema, bullies, erosions |
NP |
Predominant linear IgA deposits with C3 and C1q on DEJ |
negative |
20 |
2 |
M |
2 |
+ |
Genital erosions |
Scalp, trunk, limbs |
Erythema, bullae, |
NP |
Predominant linear IgA deposits with C3 and C1q |
NPF |
21 |
3 |
F |
3 |
+ |
- |
Face, limbs |
Erythema, Vesiculo-bullae, erosions |
NP |
Predominant linear IgA deposits with IgG and C3 on DEJ |
NPF |
22 |
12 |
F |
10 |
+ |
- |
Trunk, buttocks, lower limbs |
Vesiculo-bullae, erosions, impetigo-like lesions |
SEB, dermal inflammation |
Predominant linear IgA deposits with IgG on DEJ |
NPF |
23 |
7 |
F |
7 |
+ |
- |
Face, neck, buttocks, peri-anal region, limbs |
Bullae and pustules |
SEB, dermal inflammation |
Linear IgA deposits on DEJ |
NPF |
24 |
2 |
M |
1 |
- |
- |
Lower legs |
Vesiculo-bullae, erosions |
NP |
Predominant linear IgA deposits with C1q on DEJ |
NPF |
25 |
8 |
F |
5 |
- |
- |
Lower legs |
Vesiculo-bullae, erosions, impetigo-like lesions |
NP |
Linear IgA deposits on DEJ |
NPF |
26 |
4 |
M |
4 |
+ |
- |
Face, buttocks, genitalia, limbs |
Erythema, infected vesiculo-bullae, erosions |
SEB, dermal inflammation |
Linear IgA deposits on DEJ |
NPF |
27 |
16 |
M |
14 |
NP |
- |
Upper and lower limbs |
Bullae |
NP |
Linear IgA deposits on DEJ |
NPF |
28 |
12 |
M |
11 |
+ |
- |
Genitalia, lower limbs |
Vesiculo-bullae |
SEB, dermal inflammation |
Predominant linear IgA deposits with IgM on DEJ |
NPF |
29 |
1.5 |
M |
1 |
+ |
- |
Scalp, face, trunk, limbs |
Vesiculo-bullae, erosions |
SEB, dermal inflammation |
Predominant linear IgA deposits with C3 on DEJ |
NPF |
30 |
11 |
M |
9.5 |
+ |
- |
Face, perineum, limbs |
Erythema, Vesiculo-bullae |
SEB, dermal inflammation with neutrophils |
Predominant linear IgA deposits with IgM on DEJ |
Negative |
31 |
7 |
M |
7 |
- |
- |
Trunks, limbs |
Erythema, Vesiculo-bullae |
SEB, dermal inflammation |
Predominant linear IgA deposits on DEJ |
NPF |
Abbreviations: LAD: linear IgA dermatosis; y:years ; mth(s): month(s); NP: not precised; LF: lost to follow-up;
DEJ: dermal epidermal junction, NPF: not performed ; BMZ: basement membrane zone ; DIF: Direct immunofluorescence; IIF: indirect immunofluorescence